4 research outputs found
634 RESULTS FROM THE BARRETT'S OESOPHAGUS TRIAL 3 (BEST3): A RANDOMISED CONTROLLED TRIAL COMPARING THE CYTOSPONGEâ„¢-TFF3 TEST WITH USUAL CARE TO IDENTIFY OESOPHAGEAL PRECANCER IN PRIMARY CARE PATIENTS WITH CHRONIC GASTROESOPHAGEAL REFLUX
No full textAGA Abstrac
RESULTS FROM THE BARRETT'S OESOPHAGUS TRIAL 3 (BEST3): A RANDOMISED CONTROLLED TRIAL COMPARING THE CYTOSPONGE (TM)-FF3 TEST WITH USUAL CARE TO IDENTIFY OESOPHAGEAL PRE-CANCER IN PRIMARY CARE PATIENTS WITH CHRONIC GASTROESOPHAGEAL REFLUX
No full textMeeting Abstract 634 from Crohn's and Colitis Congress, Austin, TX, JAN 23-25, 202
